Cite
HARVARD Citation
Shome, D. et al. (2022). Efficacy of QR678 Neo® hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study. Journal of cosmetic dermatology. pp. 16-23. [Online].